OKUR — Onkure Therapeutics Share News
0.000.00%
Last trade - 00:00- $102.05m
- -$74.34m
U.S. STOCKS ON THE MOVE-First Solar, Fusion Pharmaceuticals, MicroStrategy
U.S. STOCKS ON THE MOVE-Tesla, Gold miners, Weyerhaeuser
U.S. STOCKS ON THE MOVE-Reneo Pharma, Cytokinetics, Burford Capital
Reneo Pharma rises on Concerta's $60 mln acquisition offer
Reneo Pharma up on acquisition offer from Concentra Biosciences
Brief: Tang Capital Partners Says On Dec 26, Concentra, An Affiliate Of Tang Capital Partners, Sent Acquisition Proposal To Reneo Pharmaceuticals Inc
Brief: Novo Holdings A/S Reports 0% Stake In Reneo Pharmaceuticals As Of December
Brief: Reneo Pharmaceuticals Announces Results From Pivotal Stride Study Of Mavodelpar In Primary Mitochondrial Myopathies
Brief: Reneo Pharmaceuticals Files For Mixed Shelf Of Up To $300 Mln - SEC Filing
Brief: Reneo Pharmaceuticals Q3 EPS USD -0.57
Reneo Pharmaceuticals Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Reneo Pharmaceuticals Announces Last Patient Last Visit In The Pivotal Stride Study Of Mavodelpar In Primary Mitochondrial Myopathies
Reneo Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Reneo Pharmaceuticals, Inc. Q2 EPS USD -0.65
Reneo Pharmaceuticals Inc expected to post a loss of 52 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Energy firms, Copper miners, US banks
BofA initiates Reneo Pharmaceuticals with 'buy' on 'sustained strength'
Brief: Reneo Pharmaceuticals Added To Russell 2000® And Russell 3000® Indices
Reneo Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary